|
QuintilesIMS Real-World Insights Bibliography
| Direct Costs of Type 2 Diabetes from fhe Brazilian Public Healthcare Sector Perspective |
| Author(s): Hnoosh A1, Babineaux SM2, Piras de Oliveira C3, McDonell A1, Vega-Hernandez G1 |
| Affiliations(s): 1IMS, London, England, 2Eli Lilly & Company, Indianapolis, IN, USA, 3Eli Lilly do Brasil, Sao Paulo, Brazil |
Publication(s): ISPOR 4th Latin America Conference.
Value in Health 2013 |
| Document Type(s): Poster |
| Countries: Brazil |
C:
Y: |
Diabetes
2013 |
|
L:
A: |
English
Burden of illness, Cost analysis, Cost of illness |
|
 |
| |
| |
| Direct Medical Management Costs of Diabetes-Related Complications in Brazil |
| Author(s): Vega-Hernández G1; Hnoosh A1; Jugrin A1; Todorova L2; Hansen BB3 |
| Affiliations(s): 1 IMS Health, HEOR, London, UK; 2 Novo Nordisk International Operations, Zurich, Switzerland; 3 Novo Nordisk A/S, Soeborg, Denmark |
| Publication(s): ISPOR 17th Annual International Meeting, June 2-6 2012, Washington, USA |
| Document Type(s): Abstract |
| Countries: Brazil |
C:
Y: |
Diabetes
2012 |
|
L:
A: |
English
Cost analysis |
|
|
| |
| |
|
|
|
